Showing results (1-10 of 134) with videos related to
Sort By:
Pageof 14
Cancer Treatment Reviews|February 15, 2012
Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinomaAlain Ravaud, Marine Gross-GoupilBulletin Du Cancer|July 5, 2020
[Innovations in systemic treatment of urothelial carcinoma]Constance Thibault, Marine Gross-GoupilCurrent Urology Reports|December 6, 2011
Targeted therapies in metastatic renal cell carcinoma: overview of the past yearMarine Gross-Goupil, Christophe Massard, Alain RavaudSeminars in Oncology|August 27, 2013
Combination therapy in metastatic renal cell cancerAlain Ravaud, Marine Gross-Goupil, Joaquim BellmuntExpert Opinion on Investigational Drugs|August 11, 2012
Lapatinib and renal cell carcinomaMarine Gross-Goupil, Jean-Christophe Bernhard, Alain RavaudBulletin Du Cancer|July 5, 2020
Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAveMarine Gross-Goupil, Charlotte Domblides, Felix Lefort, et al.Bulletin Du Cancer|April 24, 2012
[Strategy in advanced castration-resistant prostate cancer]Marine Gross-Goupil, Sophie Roca, Gilles Pasticier, et al.Clinical Medicine Insights. Oncology|November 20, 2013
Axitinib: a review of its safety and efficacy in the treatment of adults with advanced renal cell carcinomaMarine Gross-Goupil, Louis François, Amandine Quivy, et al.Expert Opinion on Emerging Drugs|November 27, 2013
Emerging antiangiogenics for renal cancerCharlotte Domblides, Marine Gross-Goupil, Amandine Quivy, et al.Expert Opinion on Pharmacotherapy|December 17, 2013
Protein kinase inhibitors in renal cell carcinomaAmaury Daste, Thomas Grellety, Marine Gross-Goupil, et al.Pageof 14